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Background: Right ventricular (RV) failure is a common complication of left ventricular assist devic-
es (LVAD).1,2 We describe two cases of durable LVAD carriers requiring acute RV mechanical support 
provided using the ProtekDuo (LivaNova, IT) cannula, implanted via the right jugular internal vein, 
bypassing the RV by draining blood from the right atrium to an extracorporeal blood pump (Rotaflow 
pump, Maquet, DE) and returning it to the pulmonary artery (Figure 1). 
Case report 1: A 37-year-old male following LVAD implantation in 2016 due to dilated cardiomyopathy, 
was diagnosed with chronic RV failure in 2018. During a subsequent episode of of acute RV failure 
parenteral furosemide, dobutamine and intermittent levosimendan were started. Due to ensuing car-
diogenic shock, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was placed. Three 
days later, an upgrade to a paracorporeal RVAD (p-RVAD) by placement of a ProtekDuo cannula and Ro-
taflow pump providing a flow of 4.15 litres/minute was performed. An improvement of hemodynamic 
parameters was obtained with the p-RVAD, but while awaiting the high-urgent heart transplantation, 
multiorgan failure and repetitive infections ensued, leading to the patients’ death. 
Case report 2: In April 2020, a 28-year-old male earlier diagnosed with dilated cardiomyopathy was 
admitted for acute heart failure. Echocardiography showed a predominant left ventricular cardiomyo-
pathy with significantly reduced LV ejection fraction of 15%. One week after admission, ventricular 
fibrillation occurred, terminated by implantable cardioverter-defibrillator. Due to hemodynamic com-
Figure 1.  A) Chest X-ray after HM3 and ProtekDuo placement. B) Transthoracal echocardiography 
subcostal 4-chamber view. red arrows indicate ProtekDuo cannula, red arrowhead indicates the tip of the 
cannula in the pulmonary artery. Yellow arrows indicate implantable-cardioverter defibrillator electrode.
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promise, dobutamine and norepinephrine were started, but VA-ECMO was required soon thereafter. Three days later, a durable 
LVAD (HeartMate 3, Abbott, USA) implantation was performed, however the patient was not weanable from cardiopulmonary by-
pass due to acute RV failure, and promptly received a p-RVAD with the ProtekDuo cannula. Two weeks later, the p-RVAD was suc-
cessfully weaned and he was discharged a month later and is currently in regular follow-up. 
Conclusion: We present two cases of acute and chronic RV failure in LVAD carriers. In both cases, the ProtekDuo cannula enabled 
acute RV support. Early institution of RV mechanical circulatory support, when needed, should improve patient outcomes. 
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